Treatment of secondary hyperparathyroidism in patients on hemodialysis using a novel synthetic peptide calcimimetic, etelcalcetide: a short-term clinical study

OBJECTIVE: Secondary hyperparathyroidism (SHPT) is a major complication in patients with chronic kidney disease (CKD). SHPT is related to chronic kidney disease-mineral bone disorder, leading to increased morbidity and mortality. Etelcalcetide is intravenously administered at the end of hemodialysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mima, Akira, Tansho, Kosuke, Nagahara, Dai, Watase, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259360/
https://www.ncbi.nlm.nih.gov/pubmed/30027791
http://dx.doi.org/10.1177/0300060518786913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259360/
https://www.ncbi.nlm.nih.gov/pubmed/30027791
http://dx.doi.org/10.1177/0300060518786913

Ejemplares similares